Clinical Trial Update: A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating mycophenolate mofetil (CellCept) for lupus nephritis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Lupus Nephritis | Phase 3 | Status: COMPLETED | Results posted: 2011-12-06